New drug ASKG915 tested in advanced cancer patients
Disease control
Recruiting now
This study tests a new drug called ASKG915, alone or with standard treatments, in people with advanced solid tumors that have not responded to other therapies. The main goals are to check safety and find the right dose. About 594 participants will take part in this early-phase tr…
Phase: PHASE1, PHASE2 • Sponsor: AskGene Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 01:36 UTC